AU2012343826A1 - Haploid cells - Google Patents

Haploid cells Download PDF

Info

Publication number
AU2012343826A1
AU2012343826A1 AU2012343826A AU2012343826A AU2012343826A1 AU 2012343826 A1 AU2012343826 A1 AU 2012343826A1 AU 2012343826 A AU2012343826 A AU 2012343826A AU 2012343826 A AU2012343826 A AU 2012343826A AU 2012343826 A1 AU2012343826 A1 AU 2012343826A1
Authority
AU
Australia
Prior art keywords
cells
cell
haploid
embryonic stem
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2012343826A
Other languages
English (en)
Inventor
Ulrich Elling
Josef Penninger
Jasmin TAUBENSCHMID
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMBA Institut fur Molekulare Biotechonologie GmbH
Original Assignee
IMBA Institut fur Molekulare Biotechonologie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMBA Institut fur Molekulare Biotechonologie GmbH filed Critical IMBA Institut fur Molekulare Biotechonologie GmbH
Publication of AU2012343826A1 publication Critical patent/AU2012343826A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
AU2012343826A 2011-11-30 2012-11-30 Haploid cells Abandoned AU2012343826A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP11191408.1 2011-11-30
EP11191408.1A EP2599859A1 (en) 2011-11-30 2011-11-30 Haploid cells
US201161565626P 2011-12-01 2011-12-01
US61/565,626 2011-12-01
PCT/EP2012/074112 WO2013079670A1 (en) 2011-11-30 2012-11-30 Haploid cells

Publications (1)

Publication Number Publication Date
AU2012343826A1 true AU2012343826A1 (en) 2014-06-12

Family

ID=45218335

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012343826A Abandoned AU2012343826A1 (en) 2011-11-30 2012-11-30 Haploid cells

Country Status (11)

Country Link
US (1) US20140342369A1 (enExample)
EP (2) EP2599859A1 (enExample)
JP (1) JP2015500637A (enExample)
KR (1) KR20140101390A (enExample)
CN (1) CN104024404A (enExample)
AU (1) AU2012343826A1 (enExample)
CA (1) CA2856810A1 (enExample)
IL (1) IL232879A0 (enExample)
IN (1) IN2014KN01374A (enExample)
SG (1) SG11201402350QA (enExample)
WO (1) WO2013079670A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9957479B2 (en) 2011-03-02 2018-05-01 Anton Wutz Mammalian haploid embryonic stem cells
WO2015152146A1 (ja) * 2014-03-31 2015-10-08 国立大学法人東京医科歯科大学 １倍体胚性幹細胞の培養方法
SG10201913367SA (en) * 2015-07-29 2020-02-27 New York Stem Cell Foundation Inc Haploid human embryonic stem cell lines and somatic cell lines and methods of making the same
WO2017221225A1 (en) * 2016-06-19 2017-12-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Screening for chemotherapy resistance in human haploid cells
WO2018020050A1 (en) 2016-07-29 2018-02-01 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Targeted in situ protein diversification by site directed dna cleavage and repair
EP3388530A1 (en) 2017-04-13 2018-10-17 IMBA-Institut für Molekulare Biotechnologie GmbH Nucleic acid modification and identification method
WO2018189367A1 (en) 2017-04-13 2018-10-18 Imba - Institut Für Molekulare Biotechnologie Gmbh Nucleic acid modification and identification method
CN108998410B (zh) * 2017-06-07 2020-11-06 中国科学院动物研究所 蛋白激酶抑制剂在抑制单倍体细胞二倍化中的用途
CN107217042B (zh) * 2017-07-31 2020-03-06 江苏东抗生物医药科技有限公司 一种生产无岩藻糖基化蛋白的基因工程细胞系及其建立方法
US10626319B1 (en) 2019-05-17 2020-04-21 King Fahd University Of Petroleum And Minerals Methods of inhibiting corrosion with a pyrazine corrosion inhibitor
CN118389411A (zh) * 2024-06-21 2024-07-26 中国科学院昆明动物研究所 一种小鼠双单倍体胚胎干细胞分离建系的方法
CN118370275B (zh) * 2024-06-21 2024-09-06 中国科学院昆明动物研究所 一种产生母源性半克隆小鼠的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945577A (en) 1997-01-10 1999-08-31 University Of Massachusetts As Represented By Its Amherst Campus Cloning using donor nuclei from proliferating somatic cells
EP1092768A1 (en) 1999-10-16 2001-04-18 ARTEMIS Pharmaceuticals GmbH Conditional gene trapping construct for the disruption of genes
EP1230342A4 (en) 1999-10-28 2003-04-09 Univ Massachusetts GYNOGENETIC OR ANDROGENETIC PRODUCTION OF PLURIPOTENT CELLS AND CELL LINES AND THEIR USE IN THE PRODUCTION OF DIFFERENTIATED CELLS AND TISSUES
JP2003512848A (ja) 1999-11-02 2003-04-08 ユニバーシティ オブ マサチューセッツ、アズ リプリゼンティッド バイ イッツ アマースト キャンパス 遺伝的診断、修飾および増殖のための一倍体ゲノムの使用
US7074611B2 (en) 2001-04-27 2006-07-11 Gie-Cerbn, Centre Europeen De Recherche En Biologie Et En Medecine (Gie) Method for the stable inversion of DNA sequence by site-specific recombination and DNA vectors and transgenic cells thereof
WO2004053078A2 (en) 2002-12-09 2004-06-24 Boehringer Ingelheim Pharmaceuticals, Inc. METHODS FOR MODULATING IKKα ACTIVITY
ES2705683T3 (es) 2002-12-16 2019-03-26 Technion Res & Dev Foundation Medio de cultivo de células madre pluripotentes
ATE497541T1 (de) 2004-11-26 2011-02-15 Frankgen Biotechnologie Ag Gen-fallen-kassette für eine gerichtete und ungerichtete konditionelle geninaktivierung
EP1662005A1 (en) 2004-11-26 2006-05-31 FrankGen Biotechnologie AG Enhancer-containing gene trap vectors for random and targeted gene trapping
US20100069251A1 (en) 2006-09-15 2010-03-18 Children's Medical Center Corporation Methods for producing embryonic stem cells from parthenogenetic embryos
EP2155861B1 (en) * 2007-04-06 2018-09-05 International Stem Cell Corporation Patient-specific stem cell lines derived from human parthenogenetic blastocysts
US9957479B2 (en) * 2011-03-02 2018-05-01 Anton Wutz Mammalian haploid embryonic stem cells

Also Published As

Publication number Publication date
KR20140101390A (ko) 2014-08-19
EP2785832A1 (en) 2014-10-08
IL232879A0 (en) 2014-07-31
IN2014KN01374A (enExample) 2015-10-16
JP2015500637A (ja) 2015-01-08
CA2856810A1 (en) 2013-06-06
SG11201402350QA (en) 2014-06-27
US20140342369A1 (en) 2014-11-20
EP2599859A1 (en) 2013-06-05
CN104024404A (zh) 2014-09-03
WO2013079670A1 (en) 2013-06-06

Similar Documents

Publication Publication Date Title
AU2012343826A1 (en) Haploid cells
Kim et al. Oct4-induced pluripotency in adult neural stem cells
JP2025106394A (ja) 多能性細胞のデノボ生成
Hamra et al. Defining the spermatogonial stem cell
Tian et al. Functional oocytes derived from granulosa cells
Zhang et al. Long-term propagation of porcine undifferentiated spermatogonia
US10266848B2 (en) Methods and compositions to increase somatic cell nuclear transfer (SCNT) efficiency by removing histone H3-lysine trimethylation
CN109642212A (zh) 将血液重编程成诱导多能干细胞的新型且有效的方法
JP6948650B2 (ja) 一倍体ヒト胚性幹細胞株と体細胞株およびこれらを作製する方法
WO2001053465A1 (en) Human embryoid body-derived cells
CN105051188A (zh) 新颖方法
CN107002031B (zh) 选择分化细胞的方法
JP2021520215A (ja) リプログラミングベクター
WO2019107576A1 (ja) 始原生殖細胞／始原生殖細胞様細胞の維持増幅及び分化誘導方法
Neri et al. Mouse fibroblasts are reprogrammed to Oct-4 and Rex-1 gene expression and alkaline phosphatase activity by embryonic stem cell extracts
Fanslow et al. Genome editing in mouse spermatogonial stem/progenitor cells using engineered nucleases
Cui et al. Derivation of mouse haploid trophoblast stem cells
Vincent et al. Single cell analysis facilitates staging of Blimp1-dependent primordial germ cells derived from mouse embryonic stem cells
Yin et al. Knockdown of H19 enhances differentiation capacity to epidermis of parthenogenetic embryonic stem cells
EP3408376B1 (en) Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
CN113801851B (zh) 一种体细胞核移植方法及其应用
Harvey et al. The metabolic framework of pluripotent stem cells and potential mechanisms of regulation
Nakade et al. Efficient selection of knocked-in pluripotent stem cells using dual cassettes of cellular suicide system
Severino et al. A temporally controlled sequence of X-chromosome inactivation and reactivation defines female mouse in vitro germ cells with meiotic potential
엄경현 Strategies for Rapid Propagation of Gene-Edited Cattle

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application